Center for iPS Cell Research Application (CiRA) of Kyoto University and Takeda Pharmaceutical Company Limited (Takeda) announced today that they will work together to develop clinical applications of ...

“It is a significant achievement that we have been able to confirm improvement in patients’ symptoms,” Director of Kyoto University’s Center for iPS Cell Research and Application (CiRA) Jun Takahashi ...

In reading, a bookmark tells where you stopped. Cells use bookmarks too, specific proteins that help the cell remember what collection of genes needs to be turned on again after the brief halt of gene ...

A third "just in case" service to proactively store induced pluripotent stem (iPS) cells created with a client's blood for ...

A Kyoto-based regenerative medicine company is launching a service that will allow individuals to generate and store induced ...

History is coming full circle as induced pluripotent stem (iPS) cell-derived cell therapy maker Shinobi Therapeutics links up with Panasonic and Japan’s Kyoto University, where the first mouse iPS ...

Induced pluripotent stem cells (iPS cells) can be created from any tissue in the human body and possess the ability to transform into a wide range of tissues. Kobe University MARUYAMA Tatsuo and his ...

It’s been 16 years since scientists first coaxed skin cells back into their embryonic state, a development that made it possible to sidestep the thorny ethical dilemmas around sourcing human stem ...

A Kyoto-based regenerative medicine company is launching a service that will allow individuals to generate and store induced ...